课题基金 / 基金详情

项目摘要

项目成果

ALEXANDER V KABANOV的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. The Nebraska Center for Nanomedicine (NCN), a Center of Biomedical Research Excellence (COBRE) has been created from this award. Nanomedicine is a rapidly developing area of biomedical research that uses devices of nanoscale size to address urgent needs for improved drug and gene delivery. Such "next generation" therapies can specifically deliver drugs and recombinant DNAs to focal areas of disease or to tumors to maximize clinical benefit while limiting untoward side effects. Such nanotechnologies are expected to drastically improve early diagnosis through bioimaging techniques. This parallels the road map for the National Institutes of Health (NIH) where nanomedicine was identified as a development initiative for the next decade. In keeping with these ideas, the Center will serve to join already strong areas of biomedical and material science research into an even stronger unit. Such goals can now be realized with the established expertise in biomedical sciences (neuroscience, pathology, immunology, pharmacology, immunization and cancer biology) and those in the material sciences (nanomaterials, polymers, drug delivery, and gene delivery) within the University of Nebraska Medical Center (UNMC). The primary goal of the Center is to provide a foundation for synergistic research activities and translating the efforts into clinical benefit for diseases with limited treatment options while simultaneously developing a potentially "visionary" area of science where the State of Nebraska can emerge as a world-leader.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Naturally Targeted Exosomal TLR7/8 Agonist for Immunotherapy of Medulloblastoma
  • 批准号:
    10790660
  • 项目类别:
  • 资助金额:
    $42.76万
  • 财政年份:
    2023
  • 负责人:
    ALEXANDER V KABANOV
  • 依托单位:
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
  • 批准号:
    10436355
  • 项目类别:
  • 资助金额:
    $60.08万
  • 财政年份:
    2021
  • 负责人:
    ALEXANDER V KABANOV
  • 依托单位:
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
  • 批准号:
    10684815
  • 项目类别:
  • 资助金额:
    $49.63万
  • 财政年份:
    2021
  • 负责人:
    ALEXANDER V KABANOV
  • 依托单位:
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
  • 批准号:
    10621403
  • 项目类别:
  • 资助金额:
    $11.79万
  • 财政年份:
    2021
  • 负责人:
    ALEXANDER V KABANOV
  • 依托单位:
海外基金